Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: Results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial

Journal of Clinical Oncology

Volumn 28, Issue 8, 2010, Pages 1294-1300

  Schilder, Christina M ^a   Seynaeve, Caroline ^a   Beex, Louk V ^a   Boogerd, Willem ^a   Linn, Sabine C ^a   Gundy, Chad M ^a   Huizenga, Hilde M ^a   Nortier, Johan W ^a   Van De Velde, Cornelis J ^a   Van Dam, Frits S ^a   Schagen, Sanne B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EXEMESTANE; TAMOXIFEN; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AROMATASE INHIBITOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DRUG SAFETY; EXECUTIVE FUNCTION; HORMONAL THERAPY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY; BREAST TUMOR; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; COMPARATIVE STUDY; FEMALE; MIDDLE AGED; NETHERLANDS;

AGED; AGED, 80 AND OVER; ANDROSTADIENES; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HUMANS; MIDDLE AGED; NETHERLANDS; POSTMENOPAUSE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 77950475217     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2008.21.3553     Document Type: Article

References (47)

1. Lin NU, Winer EP: Advances in adjuvant endocrine therapy for postmenopausal women. J Clin Oncol 26:798-805, 2008 (Pubitemid 351264393)
2. Buzdar AU, Coombes RC, Goss PE, et al: Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer. Cancer 112:700-709, 2008 (Pubitemid 351186392)
3. Monnier A: Clinical management of adverse events in adjuvant therapy for hormone-responsive early breast cancer. Ann Oncol 18:viii36-viii44, 2007 (suppl 8)
4. Partridge AH, Lafountain A, Mayer E, et al: Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556-562, 2008 (Pubitemid 351264348)
5. Perez EA: Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Ann Oncol 18:viii26-viii35, 2008 (suppl 8)
6. Wise PM: Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience 138:831-835, 2006
7. Turgeon JL, Carr MC, Maki PM, et al: Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr Rev 27:575-605, 2006 (Pubitemid 44582052)
8. Deroo BJ, Korach KS: Estrogen receptors and human disease. J Clin Invest 116:561-570, 2006 (Pubitemid 43326860)
9. Phillips SM, Sherwin BB: Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485-495, 1992 (Pubitemid 23015018)
10. Rocca WA, Bower JH, Maraganore DM, et al: Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69:1074-1083, 2007 (Pubitemid 47517552)
11. Shumaker SA, Legault C, Kuller L, et al: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2947-2958, 2004
12. Anderson GL, Limacher M, Assaf AR, et al: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 291:1701-1712, 2004
13. MacLennan AH, Henderson VW, Paine BJ, et al: Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: The REMEMBER pilot study. Menopause 13:28-36, 2006
14. Sherwin BB, Henry JF: Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review. Front Neuroendocrinol 29:88-113, 2008
15. Hogervorst E, Yaffe K, Richards M, et al: Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev:CD003122, 2002
16. Tralongo P, Dimari A, Repetto L: Aromatase inhibitors and mental function. J Am Geriatr Soc 53:166, 2005
17. Paganini-Hill A, Clark LJ: Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64:165-176, 2000 (Pubitemid 32010334)
18. Jenkins V, Shilling V, Fallowfield L, et al: Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 13:61-66, 2004 (Pubitemid 38139358)
19. Collins B, Mackenzie J, Stewart A, et al: Cognitive effects of hormonal therapy in early stage breast cancer patients: A prospective study. Psychooncology 18:811-821, 2009
20. Bender CM, Sereika SM, Brufsky AM, et al: Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 14:995-998, 2007 (Pubitemid 350098658)
21. Jenkins VA, Ambroisine LM, Atkins L, et al: Effects of anastrozole on cognitive performance in postmenopausal women: A randomised, double-blind chemoprevention trial (IBIS II). Lancet Oncol 9:953-961, 2008
22. Schilder CM, Eggens PC, Seynaeve C, et al: Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol 48:76-85, 2009
23. Van der Meulen EF, Schmand B, van Campen JP, et al: The seven minute screen: A neurocognitive screening test highly sensitive to various types of dementia. Journal of Neurology Neurosurgery & Psychiatry 75:700-705, 2004 (Pubitemid 38526679)
24. van den Burg W, Saan RJ, Deelman BG: 15-woordentest: Provisional Manual. Groningen, the Netherlands, University Hospital, Department of Neuropsychology, 1985
25. Lindeboom J, Schmand B, Tulner L, et al: Visual association test to detect early dementia of the Alzheimer type. Journal of Neurology Neurosurgery & Psychiatry 73:126-133, 2002
26. Wechsler D: Wechsler Memory Scale: Revised. New York, NY, Psychological Corporation, 1987
27. Hammes J: De Stroop kleur-woord test: Handleiding (ed 2). Lisse, the Netherlands, Swets & Zeitlinger, 1978
28. Reitan R: Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271-276, 1958
29. Alpherts W, Aldenkamp AP: FePsy: The iron psyche. Heemstede, the Netherlands, Instituut voor Epilepsiebestrijding, 1994
30. Van der Elst W, van Boxtel MP, Van Breukelen GJ, et al: Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. Journal of the International Neuropsychological Society 12:80-89, 2006 (Pubitemid 43379954)
31. Lezak M: Neuropsychological assessment. New York, NY, Oxford University Press, 2004
32. Wechsler D: WAIS-III Nederlandstalige Bewerking. Technische Handleiding. Lisse, the Netherlands, Swets & Zeitlinger, 2000
33. Schmand B, Lindeboom J, van Harskamp F: De Nederlandse Leestest voor Volwassenen. Lisse, the Netherlands, Swets & Zeitlinger, 1992
34. Frojdh K, Hakansson A, Karlsson I: The Hopkins Symptom Checklist-25 is a sensitive case-finder of clinically important depressive states in elderly people in primary care. Int J Geriatr Psychiatry 19:386-390, 2004 (Pubitemid 38461079)
35. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993 (Pubitemid 23073154)
36. Fallowfield LJ, Leaity SK, Howell A, et al: Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 55:189-199, 1999 (Pubitemid 29389581)
37. Winkens B, Van Breukelen GJ, Schouten HJ, et al: Randomized clinical trials with a pre- and a post-treatment measurement: Repeated measures versus ANCOVA models. Contemp Clin Trials 28: 713-719, 2007 (Pubitemid 47499251)
38. Van Breukelen GJ: ANCOVA versus change from baseline: More power in randomized studies, more bias in nonrandomized studies. J Clin Epidemiol 59:920-925, 2006
39. Schilder CM, Seynaeve C, Linn SC, et al: The impact of different definitions and reference groups on the prevalence of cognitive impairment: A study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psychooncology, 2009 (Epub ahead of print on June 10, 2009)
40. Riggs BL, Hartmann LC: Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. N Engl J Med 348:618-629, 2003 (Pubitemid 36210865)
41. Eberling JL, Wu C, Tong-Turnbeaugh R, et al: Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage 21:364-371, 2004 (Pubitemid 38115027)
42. Ariazi EA, Leitao A, Oprea TI, et al: Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen. Mol Cancer Ther 6:2817-2827, 2007 (Pubitemid 350206762)
43. Hirshman E, Merritt P, Wang CC, et al: Evidence that androgenic and estrogenic metabolites contribute to the effects of dehydroepiandrosterone on cognition in postmenopausal women. Horm Behav 45:144-155, 2004 (Pubitemid 38326871)
44. Liu F, Day M, Muniz LC, et al: Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 11:334-343, 2008 (Pubitemid 351311804)
45. Shughrue PJ, Lane MV, Merchenthaler I: Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388:507-525, 1997 (Pubitemid 27481288)
46. Wefel JS, Lenzi R, Theriault R, et al: 'Chemobrain' in breast carcinoma? A prologue. Cancer 101: 466-475, 2004
47. Ahles TA, Saykin AJ, McDonald BC, et al: Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 110: 143-152, 2008 (Pubitemid 351793851)